|Description||LY-53857 is a selective and potent 5-HT2 serotonin receptor antagonist. It was developed by Eli Lilly and Company.|
|Synonyms||6-Methyl-1-(1-methylethyl)ergoline-8β-carboxylic acid 2-hydroxy-1-methylpropyl ester maleate salt;LY53857;Ergoline-8-carboxylic acid, 6-methyl-1-(1-methylethyl)-, 2-hydroxy-1-methylpropyl ester, (8beta)-, (Z)-2-butenedioate (1:1) (salt)|
|Solubility||0.1 M HCl: 25 mg/mL|
|Quality Standard||In-house standard|
|Boiling Point||554.8°C at 760 mmHg|
|Current Developer||LY-53857 was developed by Eli Lilly and Company.|
(+)-MDL 105725 is an active metabolite of MDL 100907, which is a selective 5-HT2A antagonist.
Sunepitron hydrochloride is a potent and selective serotonin 5-HT1A autoreceptor agonist, α2-adrenergic antagonist, and dopamine D2 agonist. The phase III clini...
SUVN-502 is a 5-HT6 receptor antagonist originated by Suven Life Sciences. It has >1200-fold selectivity over 5-HT2A receptor with a superior profile that diffe...
SB 699551 is a selective 5-HT5A receptor antagonist.
A potent dual antagonist of α1-adrenergic receptor and 5-HT2 receptor
Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches.
(±)-MDL 105725 is an active metabolite of MDL 100907, which is a 5-HT2A receptor antagonist.
AVN-492 is a novel highly-potent and highly-selective 5-HT6R antagonist. The affinity of AVN-492 to bind to 5-HT6R (Ki = 91 pM) was more than three orders of ma...
Sarpogrelate is a drug under the development of Mitsubishi Chemical as 5HT2A and 5-HT2B receptor. antagonists. It is used as an antiplatelet agent and has been ...
LY 278584 is a 5-HT3-receptor antagonist and no detailed information has been published yet.
Almotriptan Malate is a selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist, used for the treatment of Migraine attacks in adults.
(-)-NPPCC is a potent and selective 5-HT1A receptor agonist.
Elzasonan, also called as CP 448187, exhibits potent and selective antagonism of 5-HT1B receptors in vitro, and preclinical in vivo studies demonstrate enhanced...
(±)-LY 426965 dihydrochloride
(±)-LY 426965 dihydrochloride is a selective 5-HT1A antagonist.
Alverine Citrate is a highly potent competitive CXCR4 antagonist with EC50 of 0.3 nM.
Ondansetron is a serotonin 5-HT3 receptor antagonist used mainly as an antiemetic.
Rupatadine, with the potential to treat allergic rhinitis and urticaria, is a potent and long-lasting dual antagonist of PAF/H1. in vitro: Without affecting con...
SB269970 HCl is a hydrochloride salt form of SB-269970, which is a 5-HT7 receptor antagonist with pKi of 8.3, exhibits >50-fold selectivity against other recept...
The (-)-enantiomer of Azasetron hydrochloride, which is a selective 5-HT3 antagonist.
Cariprazine is an orally active D2/D3 dopamine receptor antagonist exhibits high selectivity and affinity to dopamine D3(Ki=0.09 nM) and D2 (Ki=0.5 nM) receptor...